Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Rating) saw an uptick in trading volume on Wednesday . 14,273 shares were traded during trading, a decline of 62% from the previous session's volume of 37,116 shares.The stock last traded at $152.04 and had previously closed at $150.54.
First Trust NYSE Arca Biotechnology Index Fund Stock Up 1.1 %
The firm's 50-day moving average price is $157.13 and its 200 day moving average price is $150.64. The firm has a market cap of $1.45 billion, a P/E ratio of 16.29 and a beta of 0.82.
Get
First Trust NYSE Arca Biotechnology Index Fund alerts:
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Several institutional investors have recently bought and sold shares of the stock. Wade G W & Inc. lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the fourth quarter. Wade G W & Inc. now owns 5,731 shares of the company's stock worth $883,000 after purchasing an additional 100 shares during the period. Moors & Cabot Inc. lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.6% in the 3rd quarter. Moors & Cabot Inc. now owns 7,065 shares of the company's stock valued at $932,000 after acquiring an additional 109 shares during the last quarter. American Financial Advisors LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 2.9% in the 4th quarter. American Financial Advisors LLC now owns 3,815 shares of the company's stock valued at $588,000 after acquiring an additional 109 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 21.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 699 shares of the company's stock valued at $108,000 after acquiring an additional 123 shares during the last quarter. Finally, Financial Enhancement Group LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 4.1% in the 3rd quarter. Financial Enhancement Group LLC now owns 3,760 shares of the company's stock valued at $496,000 after acquiring an additional 147 shares during the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
(Get Rating)
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Articles
- Get a free copy of the StockNews.com research report on First Trust NYSE Arca Biotechnology Index Fund (FBT)
- Three Mid Caps Wall Street Sees Doubling Within 12 Months
- It's No Stretch: Lululemon Could Break Out of its Range
- Visa: Turnkey Investment to Finance Inflation-Tightened Wallets
- Three Pullback Opportunities in Tech Right Now
- Micron Technology Goes on Breakout Watch
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
First Trust NYSE Arca Biotech Index Fund(NYSEARCA:FBT-GET評級)的股票週三成交量上升。當日成交量為14,273股,較前一交易日的37,116股減少了62%。該股最新報152.04美元,此前收盤價為150.54美元。
First Trust NYSE Arca生物技術指數基金上漲1.1%
該公司的50日移動均線價格為157.13美元,200日移動均線價格為150.64美元。該公司市值為14.5億美元,本益比為16.29倍,貝塔係數為0.82。
到達
First Trust NYSE Arca生物技術指數基金警報:
機構投資者看好First Trust NYSE Arca生物技術指數基金
幾家機構投資者最近買賣了該股的股票。Wade G W&Inc.在第四季度增持了First Trust NYSE Arca Biotech Index Fund 1.8%的股份。Wade G W&Inc.在此期間又購買了100股,現在持有5,731股該公司股票,價值883,000美元。Moors&Cabot Inc.在第三季度增持了First Trust NYSE Arca Biotech Index Fund 1.6%的股份。Moors&Cabot Inc.目前持有7,065股該公司股票,價值93.2萬美元,此前該公司在上個季度增持了109股。American Financial Advisors LLC在第四季度將其在First Trust NYSE Arca Biotech Index Fund的持有量增加了2.9%。American Financial Advisors LLC現在擁有3815股該公司股票,價值58.8萬美元,在上個季度增持了109股。秀克黎世廣東銀行在第四季度增持了First Trust NYSE Arca Biotech Index Fund 21.4%的股份。Zurcher Kantonalbank秀克黎世廣東銀行在上個季度額外收購了123股後,現在擁有699股該公司股票,價值10.8萬美元。最後,金融增強集團有限責任公司在第三季度增持了First Trust NYSE Arca Biotech Index Fund 4.1%的股份。金融增強集團有限責任公司現在擁有3760股該公司的股票,價值49.6萬美元,在上個季度額外購買了147股。
關於First Trust NYSE Arca生物技術指數基金
(獲取評級)
First Trust NYSE Arca Biotech Index Fund(FBT)是一隻基於NYSE Arca生物技術指數的交易所交易基金。該基金追蹤美國生物科技股的一個同等權重指數。FBT成立於2006年6月19日,由First Trust管理。
專題文章
- 免費獲取StockNews.com關於First Trust NYSE Arca生物技術指數基金(FBT)的研究報告
- 華爾街預計三隻中型股在12個月內翻一番
- 這是不可伸展的:lululemon可以突破它的範圍
- Visa:交鑰匙投資為通脹收緊的錢包提供資金
- 眼下科技行業的三個回調機會
- 美光科技進入突破口觀察
獲得First Trust紐約證交所Arca生物技術指數基金每日新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對First Trust NYSE Arca Biotech Index Fund和相關公司的最新新聞和分析師評級的每日簡要摘要。